In 2024, the U.S. Drug Enforcement Administration (DEA) indicated that they intend to reclassify cannabis like a Plan III drug. This rescheduling will figure out that cannabis has legitimate health-related functions and can help open up the doorway to study on other prospective therapy uses.Transparency: When choosing a hemp CBD, 3rd-party lab test